MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
MetaVia Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.23−0.03 (-2.38%)
Close on Oct 19, 2026
- Market cap
- $7.30M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$9.47 (−88.50%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $7.30M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.07
- Dividend yield
- –
- Free cash flow yield
- -215.22%
Fundamentals
- Net income
- -$14.45M
- EPS, diluted
- -$7.35
- Free cash flow
- -$15.70M
- Book value per share
- $1.15
- Diluted shares
- 6M
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Operating income
-$14.93M
Net income
-$14.45M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months